Evidence map›Paper›PMID 40864090›Full record

ReviewToxins2025

Aflatoxin Exposure in Immunocompromised Patients: Current State and Future Perspectives.

Temitope R Fagbohun, Queenta Ngum Nji, Viola O Okechukwu, Oluwasola A Adelusi, Lungani A Nyathi, Patience Awong, Patrick B Njobeh

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Aflatoxin exposure and health impacts: global burden and advances in detection technologies.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Temitope R FagbohunDepartment of Biotechnology and Food Technology, University of Johannesburg, Doornfontein Campus, Johannesburg 2094, South Africa.ORCID 0000-0002-3343-7634
Queenta Ngum NjiDepartment of Biotechnology and Food Technology, University of Johannesburg, Doornfontein Campus, Johannesburg 2094, South Africa.ORCID 0000-0003-1709-8916
Viola O OkechukwuDepartment of Environmental, Water and Earth Sciences, Tshwane University of Technology, Arcadia Campus, Private Bag X680, Pretoria 0001, South Africa.
Oluwasola A AdelusiDepartment of Biotechnology and Food Technology, University of Johannesburg, Doornfontein Campus, Johannesburg 2094, South Africa.ORCID 0000-0002-5125-4380
Lungani A NyathiCentre for Innovative Food Research (CIFR), Department of Biotechnology and Food Technology, University of Johannesburg, Doornfontein Campus, Johannesburg 2094, South Africa.ORCID 0000-0003-1109-1094
Patience AwongDepartment of Health Sciences, University of Johannesburg, Doornfontein Campus, Johannesburg 2094, South Africa.ORCID 0000-0003-1388-3917
Patrick B NjobehDepartment of Biotechnology and Food Technology, University of Johannesburg, Doornfontein Campus, Johannesburg 2094, South Africa.ORCID 0000-0001-5193-3650

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aflatoxins (AFs), harmful secondary metabolites produced by the genus

Indexed as

AflatoxinsImmunocompromised HostAnimalsEnvironmental ExposureFood ContaminationHumansAflatoxinsaflatoxin biomarkersaflatoxinsdetection methodsexposure routeimmunocompromised patients

Identifiers

PMID40864090
PMCPMC12390636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.